Evidence map›Paper›PMID 38875587›Full record

ArticleJMIR AI2023

Strategies to Improve the Impact of Artificial Intelligence on Health Equity: Scoping Review.

Carl Thomas Berdahl, Lawrence Baker, Sean Mann, Osonde Osoba, Federico Girosi

Abstract readScoping Review
In one paragraph

Article in JMIR AI, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Addressing Health Disparities through Community Engagement in Artificial Intelligence-Driven Prevention Science.Prevention science : the official journal of the Society for Prevention Research · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. [Application and progress of artificial intelligence agents in drug development].Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2026
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Carl Thomas BerdahlRAND Corporation, Santa Monica, CA, United States.ORCID https://orcid.org/0000-0002-4374-3280
Lawrence BakerRAND Corporation, Santa Monica, CA, United States.ORCID https://orcid.org/0000-0001-9193-7656
Sean MannRAND Corporation, Santa Monica, CA, United States.ORCID https://orcid.org/0000-0002-5771-1458
Osonde OsobaRAND Corporation, Santa Monica, CA, United States.ORCID https://orcid.org/0000-0002-5232-2779
Federico GirosiRAND Corporation, Santa Monica, CA, United States.ORCID https://orcid.org/0000-0003-3937-2285

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEmerging artificial intelligence (AI) applications have the potential to improve health, but they may also perpetuate or exacerbate inequities.

objectiveThis review aims to provide a comprehensive overview of the health equity issues related to the use of AI applications and identify strategies proposed to address them.

methodsWe searched PubMed, Web of Science, the IEEE (Institute of Electrical and Electronics Engineers) Xplore Digital Library, ProQuest U.S. Newsstream, Academic Search Complete, the Food and Drug Administration (FDA) website, and ClinicalTrials.gov to identify academic and gray literature related to AI and health equity that were published between 2014 and 2021 and additional literature related to AI and health equity during the COVID-19 pandemic from 2020 and 2021. Literature was eligible for inclusion in our review if it identified at least one equity issue and a corresponding strategy to address it. To organize and synthesize equity issues, we adopted a 4-step AI application framework: Background Context, Data Characteristics, Model Design, and Deployment. We then created a many-to-many mapping of the links between issues and strategies.

resultsIn 660 documents, we identified 18 equity issues and 15 strategies to address them. Equity issues related to Data Characteristics and Model Design were the most common. The most common strategies recommended to improve equity were improving the quantity and quality of data, evaluating the disparities introduced by an application, increasing model reporting and transparency, involving the broader community in AI application development, and improving governance.

conclusionsStakeholders should review our many-to-many mapping of equity issues and strategies when planning, developing, and implementing AI applications in health care so that they can make appropriate plans to ensure equity for populations affected by their products. AI application developers should consider adopting equity-focused checklists, and regulators such as the FDA should consider requiring them. Given that our review was limited to documents published online, developers may have unpublished knowledge of additional issues and strategies that we were unable to identify.

Indexed as

algorithmic biasalgorithmsartificial intelligencedecision makingequitygray literaturehealth care disparitieshealth datahealth equitymachine learningsocial determinants of health

Identifiers

PMID38875587
PMCPMC11041459

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.